Abstract

Nasopharyngeal carcinoma (NPC) is a serious health problem in China and Southeast Asia. Relapse is the major cause of mortality, but mechanisms of relapse are mysterious. Epstein–Barr virus (EBV) reactivation and host genomic instability (GI) have correlated with NPC development. Previously, we reported that lytic early genes DNase and BALF3 induce genetic alterations and progressive malignancy in NPC cells, implying lytic proteins may be required for NPC relapse. In this study, we show that immediate early gene BRLF1 induces chromosome mis-segregation and genomic instability in the NPC cells. Similar phenomenon was also demonstrated in 293 and zebrafish embryonic cells. BRLF1 nuclear localization signal (NLS) mutant still induced genomic instability and inhibitor experiments revealed that BRLF1 interferes with chromosome segregation and induces genomic instability by activating Erk signaling. Furthermore, the chromosome aberrations and tumorigenic features of NPC cells were significantly increased with the rounds of BRLF1 expression, and these cells developed into larger tumor nodules in mice. Therefore, BRLF1 may be the important factor contributing to NPC relapse and targeting BRLF1 may benefit patients.

Highlights

  • Nasopharyngeal carcinoma (NPC) is a squamouscell carcinoma derived from the nasopharyngeal epithelium of the post nasal cavity

  • We show that immediate early gene BRLF1 induces chromosome mis-segregation and genomic instability in the NPC cells

  • Epstein–Barr virus (EBV) infection is associated with many human malignancies, including Burkitt’s lymphoma, posttransplant lymphoproliferative disease (PTLD) and nasopharyngeal carcinoma [8]

Read more

Summary

Introduction

Nasopharyngeal carcinoma (NPC) is a squamouscell carcinoma derived from the nasopharyngeal epithelium of the post nasal cavity. It is rare worldwide but has a very unique pattern of distinct ethnic and geographic distribution such as southern China, Southeast Asia, northeast India and North Africa [1, 2]. If treatment is started at early stages, the 5-year survival rate may be as high as 80-95%. If the treatment is started at late stages, the 5-year survival rate is poor [4]. Prevention of relapse and metastasis appears to be the most important issue in the control of NPC. To cope with this clinical difficulty, delineation of the mechanism(s) of NPC relapse and metastasis is imperative

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.